You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / WOCKHARDT

WOCKHARDT
Intrinsic Value | Fundamental Analysis

Returns | 1W : -8.8% , 1M : -14.5%,1Y : 128%
BOM : 532300     NSE : WOCKPHARMA    
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Jun 18,2021
Price(EOD): Rs. 590.20
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
MarketCap: Rs. 6,539.42 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
WOCKHARDT -8.8% -14.5% 128%
SUN PHARMACEUTICAL INDUSTRIES -1.3% -2.7% 36.8%
DR REDDYS LABORATORIES -3.2% 0.9% 32.7%
DIVIS LABORATORIES -4.4% 3.7% 87%
CIPLA -1.6% 3.9% 48.5%
BIOCON -3.1% 4.1% 0.7%
AUROBINDO PHARMA -4.2% -7.2% 22%
LUPIN -3% -4% 25.2%
TORRENT PHARMACEUTICALS -2.7% 6.3% 16%


FUNDAMENTAL ANALYSIS OF WOCKHARDT

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than WOCKHARDT Premium


VALUATION OF WOCKHARDT

 
Valuation Score
Ratio Consolidated
P/E
P/B
P/S
-
P/E Calculated based on EPS of -6.25
[ Mar2020 - Consolidated Results ]

2.47
P/B Calculated based on Book Value of 238.55
[ Mar2020 - Consolidated Results ]

2.37
P/S Calculated based on Revenues of 2763.27 Cr
[ TTM - Consolidated Results ]

Show Me the Stocks with Valuation better than WOCKHARDT Premium


FAIR VALUE OF WOCKHARDT

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
2096%
34%
29%

SHARE PRICE MOMENTUM OF WOCKHARDT

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
1.94
1.58
1.41
1.64
1.22
1.28
1.33
1.28
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
18.71 %
As on : Mar2021

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-17.28%
-243.86%
-671.27%
-429.75%
-8%
-1435.44%
-87.3%
-319.25%
QtrlyTrend
-8
Latest Qtr: Mar2021

WOCKHARDT related INDICES

BSE Indices1W1M1Y
S&P BSE 250 SMALLCAP -1.2% 6.3% 109.4%
S&P BSE ALLCAP -1.3% 5.3% 67%
S&P BSE 500 -1.3% 5.1% 65.5%
S&P BSE SMALL CAP -1.7% 7.3% 108.4%
S&P BSE MIDSMALLCAP -2% 5.9% 93.9%
S&P BSE 400 MIDSMALLCAP -2% 5.8% 93%
S&P BSE HEALTHCARE -2.9% 1.7% 53.8%
NSE Indices1W1M1Y
NIFTY 500 -1.2% 5.1% 64.9%
NIFTY500 MULTICAP 50:25:25 -1.4% 5.4% NA
NIFTY SMALLCAP250 -1.5% 6% 112.6%
NIFTY FREE SMALL 100 -1.5% 5.9% 118.2%
NIFTY SMALLCAP 50 -2% 6.9% 134.7%
NIFTY MID SMALL400 -2% 5.7% 93.9%

FAQ [Frequently Asked Questions]


Is WOCKPHARMA good for long term investment?

As on 18-Jun-2021, the Fundamentals of WOCKPHARMA are Poor and hence it's not good for long term investment ! See Financial Performance of WOCKHARDT . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is WOCKPHARMA UnderValued or OverValued?

As on 18-Jun-2021, WOCKPHARMA is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of WOCKPHARMA ?

As on 18-Jun-2021, the Intrinsic Value of WOCKPHARMA is Rs. 440.02 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 26.88
Fair Value [Median EV / Sales Model] : Rs. 440.02
Fair Value [Median Price / Sales Model] : Rs. 456.39
Median Fair Value of WOCKPHARMA : Rs. 440.02

Is WOCKPHARMA trading at a Premium or Discount?

As on 18-Jun-2021, WOCKPHARMA is trading at a Premium of 34% based on the Median Intrinsic Value!

Is it right time to buy WOCKPHARMA shares?

As on 18-Jun-2021, WOCKPHARMA is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Financial Performance of Industry Peers of WOCKPHARMA?

Check out Annual Financials of Industry Peers
Financials of SUN PHARMACEUTICAL INDUSTRIES LTD
Financials of DR REDDYS LABORATORIES LTD
Financials of DIVIS LABORATORIES LTD
Financials of CIPLA LTD
Financials of BIOCON LTD
Financials of AUROBINDO PHARMA LTD
Financials of LUPIN LTD
Financials of TORRENT PHARMACEUTICALS LTD
Financials of CADILA HEALTHCARE LTD
Financials of ABBOTT INDIA LTD
Check out Quarterly Results of Industry Peers
Quarterly Results of SUN PHARMACEUTICAL INDUSTRIES LTD
Quarterly Results of DR REDDYS LABORATORIES LTD
Quarterly Results of DIVIS LABORATORIES LTD
Quarterly Results of CIPLA LTD
Quarterly Results of BIOCON LTD
Quarterly Results of AUROBINDO PHARMA LTD
Quarterly Results of LUPIN LTD
Quarterly Results of TORRENT PHARMACEUTICALS LTD
Quarterly Results of CADILA HEALTHCARE LTD
Quarterly Results of ABBOTT INDIA LTD

What are the Frequent Comparisons with WOCKPHARMA?

Compare Analytics
WOCKHARDT LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD
WOCKHARDT LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD
WOCKHARDT LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD
WOCKHARDT LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs BIOCON LTD
WOCKHARDT LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs AUROBINDO PHARMA LTD
WOCKHARDT LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs LUPIN LTD
WOCKHARDT LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs TORRENT PHARMACEUTICALS LTD
WOCKHARDT LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CADILA HEALTHCARE LTD
WOCKHARDT LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs ABBOTT INDIA LTD
Browse Market Cap of Industry Peers
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of DIVIS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of BIOCON LTD
Market Cap of AUROBINDO PHARMA LTD
Market Cap of LUPIN LTD
Market Cap of TORRENT PHARMACEUTICALS LTD
Market Cap of CADILA HEALTHCARE LTD
Market Cap of ABBOTT INDIA LTD

Open Demat Account & Start Investing
    Affiliate Links

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z